Are all Protein Aggregates Toxic?

所有蛋白质聚集体都有毒吗?

基本信息

  • 批准号:
    10580153
  • 负责人:
  • 金额:
    $ 43.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-22 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Abnormal aggregation and deposition of misfolded proteins have been recognized as a common pathological hallmark of several neurodegenerative diseases. The goal of this project is to identify unique physicochemical properties of aggregates, shared by a large number of structurally diverse proteins (e.g. Aβ42 peptide, insulin and lysozyme), that are toxic. In general, the scientific community agrees that soluble aggregates of proteins, especially those that are in the form of proto-fibrils, are noxious. These aggregates can cause toxicity by several mechanisms such as, aberrant interaction with cellular membranes, organelles, interaction with other proteins that may be critical for cellular functions, or by clogging the protein degradation and clearing pathways. However, there is paucity in literature showing a clear correlation between aggregated proteins shape (e.g. amorphous, globular, or fibril), flexibility (e.g. flexible, or rigid), size (e.g. monomer, oligomer, or fibril), and hydrophobicity, with its associated toxicity. Our findings on Aβ42 peptide aggregation and toxicity shows that increased surface hydrophobicity of protein aggregates can contribute to an increase in cellular toxicity. We hypothesize that flexible protein aggregates with increased surface hydrophobicity may hold the key to cellular toxicity. To test this hypothesis, we will use simple but unrelated proteins (e.g. insulin and lysozyme) which are normally not toxic and compare the properties of the aggregates of these proteins with Aβ42 peptide aggregates whose role in Alzheimer’s disease is well known. We will generate diverse aggregated structures from these proteins, characterize their biochemical and biophysical properties including size, shape, flexibility, relative hydrophobicity, and measure their associated toxicity. This will also help us address: “Is it the sequence or the unique physicochemical properties of the aggregated protein that is critical for its toxicity”. As a result, it will help us identify key physicochemical properties shared by protein aggregates that are central to their toxicity.
项目概要 错误折叠蛋白的异常聚集和沉积已被认为是一种常见的病理现象。 多种神经退行性疾病的标志。该项目的目标是确定独特的物理化学 聚集体的特性,由大量结构多样的蛋白质(例如 Aβ42 肽、胰岛素 和溶菌酶),这些都是有毒的。一般来说,科学界同意可溶性蛋白质聚集体, 尤其是那些原纤维形式的,是有毒的。这些聚集体可通过以下方式引起毒性: 多种机制,例如与细胞膜、细胞器的异常相互作用、与其他物质的相互作用 可能对细胞功能至关重要的蛋白质,或阻碍蛋白质降解和清除的蛋白质 途径。然而,很少有文献表明聚集蛋白之间存在明确的相关性 形状(例如无定形、球状或原纤维)、柔性(例如柔性或刚性)、尺寸(例如单体、低聚物或 原纤维)和疏水性及其相关的毒性。我们对 Aβ42 肽聚集和毒性的发现 研究表明,蛋白质聚集体表面疏水性的增加有助于增加细胞 毒性。我们假设具有增加的表面疏水性的柔性蛋白质聚集体可能保持 细胞毒性的关键。为了检验这个假设,我们将使用简单但不相关的蛋白质(例如胰岛素和 溶菌酶),通常无毒,并将这些蛋白质的聚集体的特性与 Aβ42 肽聚集体在阿尔茨海默病中的作用众所周知。我们将产生多样化的 这些蛋白质的聚集结构,表征其生化和生物物理特性,包括 尺寸、形状、柔韧性、相对疏水性,并测量它们相关的毒性。这也将帮助我们 地址:“关键是聚集蛋白的序列还是独特的理化性质? 因为它的毒性”。因此,它将帮助我们确定蛋白质聚集体共有的关键物理化学特性 这是其毒性的核心。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ashutosh Tiwari其他文献

Ashutosh Tiwari的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ashutosh Tiwari', 18)}}的其他基金

Are all Protein Aggregates Toxic?
所有蛋白质聚集体都有毒吗?
  • 批准号:
    10798900
  • 财政年份:
    2022
  • 资助金额:
    $ 43.93万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 43.93万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 43.93万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了